Trials / Recruiting
RecruitingNCT05698459
OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer
A Phase I, Open-label, Dose Escalation Study to Evaluate the Safety ,tolerance and Pharmacokinetics of OH2 Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Binhui Biopharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
An open-label dose-escalation phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of OH2 injection via transcatheter Intraarterial infusion in patients with advanced hepatocellular carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | OH2 injection | OH2 injection administered by transcatheter Intraarterial infusion |
Timeline
- Start date
- 2023-05-05
- Primary completion
- 2025-08-01
- Completion
- 2026-01-01
- First posted
- 2023-01-26
- Last updated
- 2024-12-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05698459. Inclusion in this directory is not an endorsement.